Preclinical evaluation of syndecan-1 targeted radionuclide theranostics approach in mouse models of pancreatic cancer
00:00
Application of high frequency ultrasound and photoacoustic imaging to monitor tumor angiogenesis and response to anti-angiogenesis treatments: a preclinical study in colorectal cancer (CRC)
Application of high frequency ultrasound and photoacoustic imaging to monitor tumor angiogenesis and response to anti-angiogenesis treatments: a preclinical study in colorectal cancer (CRC)
00:00
In vivo lactate imaging with hyperpolarized (1-13C) pyruvate MRI predicts unknown molecular subtype of murine pancreatic cancer
In vivo lactate imaging with hyperpolarized (1-13C) pyruvate MRI predicts unknown molecular subtype of murine pancreatic cancer
00:00
Molecular Magnetic Resonance Imaging of Dysregulated Zinc Secretion in the Pancreas Detects Response to KRASG12D Treatment and Cancer Recurrence After Withdrawal
Molecular Magnetic Resonance Imaging of Dysregulated Zinc Secretion in the Pancreas Detects Response to KRASG12D Treatment and Cancer Recurrence After Withdrawal
00:00
Quantifying target engagement of PD-L1 to predict colorectal cancer response to an anti-PD-L1 combination of immune checkpoint inhibitor and targeted therapy.
Quantifying target engagement of PD-L1 to predict colorectal cancer response to an anti-PD-L1 combination of immune checkpoint inhibitor and targeted therapy.
08:16
Glypican-3 as Radiotheranostics Target in an Orthotopic Model of Hepatocellular Carcinoma